OPRmax is a program created to help member practices earn additional discounts based on market share. Only practices that are interested in a particular initiative join.

Since this is an opt-in program and purely voluntary, members are much more interested in maximizing their contract and being compliant.

In the first initiative under OPRmax, Aloxi, the MGI anti-emetic was selected. 

• All OPR members were invited to participate, with 90% choosing to do so.
• Compliant members earned 17% price discounts.
• Opportunities for an additional discount/rebates were available. 
• Participants saved over $500,000 in upfront pricing and rebates.
• They were able to maximize reimbursement even with the introduction of a generic anti-emetic.
• This was a purely voluntary program.

As we demonstrate how successful the voluntary program can be, we have additional market share proposals being evaluated.